ArticleiScience2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and
Haineng Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it
ArticleiScience2024
Haineng Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.